J. Ingum et al., AMNESIC EFFECTS AND SUBJECTIVE RATINGS DURING REPEATED DOSING OF FLUNITRAZEPAM TO HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 45(3), 1993, pp. 235-240
Flunitrazepam (1 mg) or placebo was administered once daily over a tre
atment period of 8 days to healthy, male volunteers to study the time
course of the effects on memory functions and on subjective ratings of
alertness and tension. The plasma level of flunitrazepam increased by
approximately 40 % (P < 0.05) during the treatment period. The mean p
re-dose level of flunitrazepam on day 4 and day 8 was approximately 0.
005 muM, and no residual effects on memory functions were observed. In
take of flunitrazepam decreased the number of freely recalled words by
about 85 % (P < 0.05) and significantly affected the subjects' rating
of attention when tested during the first few hours after drug intake
on day 1 of treatment. However, no significant effect on the subjects
' rating of relaxation was observed. When tested similarly after 8 day
s treatment, flunitrazepam significantly affected the subjects' rating
of relaxation (P < 0.01). Furthermore, no tolerance developed for the
effect of flunitrazepam on free recall (P > 0.3) and the subjects, ra
ting of attention (P > 0.7), and these effects had nearly equal time c
ourses during the treatment period. This may indicate that the amnesic
effect of benzodiazepines is at least partially mediated through the
effects on attention or general arousal. Two of the subjects in the ac
tive drug group reported adverse reactions or incidents of discomfort
during the 1 st week following the treatment period, whereas none in t
he placebo group reported such reactions.